You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

Investigational Drug Information for Mephedrone


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Mephedrone?

Mephedrone is an investigational drug.

There have been 4 clinical trials for Mephedrone. The most recent clinical trial was a Phase 1 trial, which was initiated on January 30th 2020.

The most common disease conditions in clinical trials are Amphetamine-Related Disorders, Substance-Related Disorders, and Disease. The leading clinical trial sponsors are Instituto de Salud Carlos III, Parc de Salut Mar, and Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia.

There are twenty-seven US patents protecting this investigational drug and five hundred and sixteen international patents.

Recent Clinical Trials for Mephedrone
TitleSponsorPhase
Abuse Potential and Human Pharmacology of MethyloneFundació Recerca Institut Germans Trias i PujolPhase 1
Abuse Potential and Human Pharmacology of MethyloneIstituto Superiore di SanitàPhase 1
Abuse Potential and Human Pharmacology of MethyloneGermans Trias i Pujol HospitalPhase 1

See all Mephedrone clinical trials

Clinical Trial Summary for Mephedrone

Top disease conditions for Mephedrone
Top clinical trial sponsors for Mephedrone

See all Mephedrone clinical trials

US Patents for Mephedrone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mephedrone ⤷  Sign Up Compositions and methods for treating psychiatric disorders GOSFORTH CENTRE (HOLDINGS) PTY LTD. (Maroochydore, Queensland, AU) ⤷  Sign Up
Mephedrone ⤷  Sign Up Bile acid receptor agonism for treating addiction Vanderbilt University (Nashville, TN) ⤷  Sign Up
Mephedrone ⤷  Sign Up Topical compositions and methods of treatment of topical disorders PeriTech Pharma Ltd. (Herzliya, IL) ⤷  Sign Up
Mephedrone ⤷  Sign Up Topical compositions and methods of treatment of anorectal disorders PeriTech Pharma Ltd. (Herzilya, IL) ⤷  Sign Up
Mephedrone ⤷  Sign Up Small molecule agonists of neurotensin receptor 1 SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) ⤷  Sign Up
Mephedrone ⤷  Sign Up Preparation of desiccated liposomes for use in compressible delivery systems SMARTEK INTERNATIONAL LLC (Livingston, NJ) ⤷  Sign Up
Mephedrone ⤷  Sign Up Triazole agonists of the APJ receptor AMGEN INC. (Thousand Oaks, CA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Mephedrone

Drugname Country Document Number Estimated Expiration Related US Patent
Mephedrone European Patent Office EP2812438 2032-01-09 ⤷  Sign Up
Mephedrone World Intellectual Property Organization (WIPO) WO2013106464 2032-01-09 ⤷  Sign Up
Mephedrone World Intellectual Property Organization (WIPO) WO2017087278 2032-01-09 ⤷  Sign Up
Mephedrone Australia AU2009279372 2028-08-06 ⤷  Sign Up
Mephedrone Canada CA2732131 2028-08-06 ⤷  Sign Up
Mephedrone China CN102170874 2028-08-06 ⤷  Sign Up
Mephedrone European Patent Office EP2331088 2028-08-06 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.